Overview

Effect of Minocycline & Amoxicillin on Antibiotic Resistant Bacteria and Indigenous Microbiotas

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
A randomised, open labelled study design is selected in order to determine the emergence and persistence of antibiotic resistant bacteria in humans and on the composition of the indigenous microbiotas at various body sites. These will involve the administration to volunteers of minocycline and amoxicillin- a control group will receive a placebo. Microbiology of the skin, saliva, faecal, skin and nasal micro flora, safety and adverse events, vital signs, will be evaluated. The objectives of metagenomic analysis are: - To identify the in vivo molecular mechanisms responsible for antibiotic resistance and its transfer in the indigenous oral and faecal microbiotas using metagenomics resistome analysis. - To determine the impact of the use of antimicrobial agents on the oral resistome - To determine the impact of the use of antimicrobial agents on the faecal resistome - To determine the ecological impact of the use of antimicrobial agents on the relative abundance of phylotypes of the indigenous oral microbiota - To determine the ecological impact of the use of antimicrobial agents on the relative abundance of phylotypes of the indigenous faecal microbiotas
Phase:
Phase 4
Details
Lead Sponsor:
Helperby Therapeutics Ltd
Collaborator:
Richmond Pharmacology Limited
Treatments:
Amoxicillin
Anti-Bacterial Agents
Antibiotics, Antitubercular
Minocycline